Harbor Capital Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,607
| Closed | -$198K | – | 1515 |
|
|
2024
Q4 | $198K | Sell |
25,607
-10,475
| -29% | -$81K | 0.01% | 660 |
|
|
2024
Q3 | $379K | Buy |
36,082
+11,784
| +48% | +$124K | 0.02% | 608 |
|
|
2024
Q2 | $284K | Sell |
24,298
-30,303
| -55% | -$354K | 0.02% | 616 |
|
|
2024
Q1 | $1.15M | Buy |
54,601
+5,052
| +10% | +$106K | 0.15% | 179 |
|
|
2023
Q4 | $889K | Buy |
49,549
+990
| +2% | +$17.8K | 0.17% | 152 |
|
|
2023
Q3 | $799K | Buy |
48,559
+4,453
| +10% | +$73.3K | 0.17% | 148 |
|
|
2023
Q2 | $882K | Buy |
44,106
+19,830
| +82% | +$396K | 0.18% | 150 |
|
|
2023
Q1 | $459K | Sell |
24,276
-2,409
| -9% | -$45.6K | 0.13% | 149 |
|
|
2022
Q4 | $605K | Sell |
26,685
-574
| -2% | -$13K | 0.59% | 57 |
|
|
2022
Q3 | $720K | Sell |
27,259
-2,992
| -10% | -$79K | 0.66% | 50 |
|
|
2022
Q2 | $747K | Sell |
30,251
-2,209
| -7% | -$54.5K | 0.57% | 57 |
|
|
2022
Q1 | $1.08M | Sell |
32,460
-5,793
| -15% | -$192K | 0.51% | 59 |
|
|
2021
Q4 | $1.25M | Buy |
+38,253
| New | +$1.25M | 0.46% | 63 |
|